"Performance of HPV DNA Test in Presence of Co-infection With Common RTIs"
Cervical Inflammation and Human Papilloma Virus Performance
About this trial
This is an interventional screening trial for Cervical Inflammation and Human Papilloma Virus Performance
Eligibility Criteria
Inclusion Criteria:
- Sexually active women with clinically diagnosed cervicitis as per NACO guidelines will be enrolled as cases.
- Sexually active women with no symptoms of STIs/RTIs and clinically no cervicitis will be enrolled as cases.
Exclusion Criteria:
- Pregnant women.
- Women not willing to follow up.
- Not willing to use barrier contraception if diagnosed with STIs.
- Women received antiboitics in last 4 weeks.
- women with vaginitis without cervicitis on per speculum examination.
- No drug allergy to the treating drugs.
- No present or past history of cervical cancer. -
Sites / Locations
- Tata Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention group/Case
Control group
women with clinical cervicitis or cervicovaginitis as per NACO Guidelines will be enrolled in intervention group. women with clinical cervicitis or cervicovaginitis as per NACO Guidelines will be enrolled in intervention group.A cervico-vaginal swab shall be taken for Lab diagnosis of RTIs along with HPVDNA test on day 1.Women shall be treated with Tab Azithromycin 1gm and Tab Cefixime 400mg stat along with barrier contraception advised.The women will be followed up after 7-14 days .A repeat cervicovaginal swab and HPVDNA shall be repeated.
Women without signs and symptoms of cervicitis or cervico-vaginitis.No intervention will be done in this group